Differences in Expansion Potential of Naive Chimeric Antigen Receptor T Cells from Healthy Donors and Untreated Chronic Lymphocytic Leukemia Patients-Reference-Cited by-同舟云学术

Differences in Expansion Potential of Naive Chimeric Antigen Receptor T Cells from Healthy Donors and Untreated Chronic Lymphocytic Leukemia Patients

Published:2018-01-10 Issue: Volume:8 Page:
ISSN:1664-3224
Container-title:Frontiers in Immunology
language:
Short-container-title:Front. Immunol.

Author:

Hoffmann Jean-Marc,Schubert Maria-Luisa,Wang Lei,Hückelhoven Angela,Sellner Leopold,Stock Sophia,Schmitt Anita,Kleist Christian,Gern Ulrike,Loskog Angelica,Wuchter Patrick,Hofmann Susanne,Ho Anthony D.,Müller-Tidow Carsten,Dreger Peter,Schmitt Michael

Publisher

Frontiers Media SA

Subject

Immunology,Immunology and Allergy

Reference44 articles.

1. Design and development of therapies using chimeric antigen receptor-expressing T cells;Dotti;Immunol Rev,2014

2. CAR-T cell therapy for lymphoma;Ramos;Annu Rev Med,2016

3. CD19-CAR trials;Ramos;Cancer J,2014

4. CD19-targeted CAR T-cell therapeutics for hematologic malignancies: interpreting clinical outcomes to date;Park;Blood,2016

5. Chimeric antigen receptor T cell therapy targeting CD19-positive leukemia and lymphoma in the context of stem cell transplantation;Schubert;Hum Gene Ther,2016

Cited by 85 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An integrated perspective on measuring cytokines to inform CAR-T bioprocessing;Biotechnology Advances;2024-10

2. Next-generation BCMA-targeted chimeric antigen receptor CARTemis-1: the impact of manufacturing procedure on CAR T-cell features;Cellular Oncology;2024-08-27

3. Generation of CAR-TSCM: CAR-T with super clutch;International Immunopharmacology;2024-07

4. Advancing CAR T-cell therapy for chronic lymphocytic leukemia: exploring resistance mechanisms and the innovative strategies to overcome them;Cancer Drug Resistance;2024-05-14

5. The immunoglobulin superfamily ligand B7H6 subjects T cell responses to NK cell surveillance;Science Immunology;2024-05-03